Transforming Biopharma

How pharma is turning CRM ambition into action, value and outcomes

Companies are making meaningful progress in bringing barriers-driven engagement™ to life—embedding orchestration into workflows and rethinking how CRM supports smarter de

‘Everything changes at the same time’: On conversational AI with Veeva’s Arno Sosna

In this episode, Arno Sosna, president of the CRM Suite at Veeva, joins Maria Whitman to explore how AI is transforming CRM in life sciences into a dynamic engine for ins

‘Move slow to go fast’: Keeping pace with responsible AI with Michael Shaw

The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS Principal Michael Shaw joins the podcast to discu

Cultivating resilience: Building a better supply chain with McKesson’s Ammie McAsey

As senior vice president of customer distribution experience at McKesson, Ammie McAsey makes it a point to connect her day-to-day work with the company’s mission of impro

‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases

Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. He joins Maria Whitman

‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler

How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engageme

‘We’re all tech leaders now’: A conversation with Salesforce’s Kyrsten Musich

The opportunities to reshape customer engagement have never been greater for pharma, but what role does the customer relationship management (CRM) system play? Kyrsten Mu

How CRM can help pharma break barriers and transform customer engagement

Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management (CRM) system. ZS expert

Expanding access to cell and gene therapies with McKesson’s Joe DePinto

Joe DePinto, McKesson’s head of cell and gene advanced therapies, supports patients, providers and payers throughout the treatment journey. He’s particularly passionate a

Future focus: How the AHA is tackling cardiac health and more with Juliana Crawford

If we want to make change in healthcare, we can’t take a one-dimensional approach. We need a multifaceted plan. Having just celebrated its 100th anniversary, the American

Advancing pharma research for everyone: The clinical site perspective

Clinical trial sites are important players in biopharma’s success. In this episode, we hear from site experts Lauren Wall of the University of Chicago and Caroline Smith

‘Culture is critical to performance’: Aligning values and strategy with Paul Ingram

What’s the role of culture in an organization and how can it play a pivotal role in shaping performance or even helping businesses transform? Maria Whitman sits down with

Beyond process improvement: Why organizational architecture matters with Mike Tushman

Maria Whitman interviews Mike Tushman, professor at Harvard Business School, about the importance of organizational architecture during times of transformation. He descri

Navigating the system, meeting patients where they are with Oya Gilbert

How can healthcare and biopharma meet patients where they are? Maria Whitman interviews Oya Gilbert, a podcaster and patient advocate, about his journey as a multiple mye

From data collection to data connection: Reinventing pharma’s commercial model

How can pharma use AI and other technology to deliver a better customer experience? Maria Whitman and a panel of ZS experts discuss pharma’s next-generation commercial mo

Resetting how we think about obesity: A patient’s point of view

Recent headlines about the use of prescription drugs for weight loss make obesity a prominent and relevant topic in today’s discussions about health and well-being. Bill

Living with myeloma: Patient advocate Yelak Biru’s story

Yelak Biru, president and CEO of the International Myeloma Foundation, is passionate about patient advocacy with good reason—he’s been one himself for 28 years. Yelak joi

Disruptors, influencers and the modern customer experience with Arun Shastri

As biopharma transforms its commercial model, what can it learn from other industries? To find out, Maria Whitman sits down with Arun Shastri, global AI practice lead at

On the path to digital transformation with Madhavi Ramakrishna

Madhavi Ramakrishna, global vice president and chief digital officer of commercial, GSK, is passionate about data and technology. A former executive in broadcast media, s

‘Patients first, people always’: Science and strategy with Savitri Basavaiah

Savitri Basavaiah, vice president portfolio and commercialization strategy at Janssen, the Pharmaceutical Companies of Johnson & Johnson, has a deep background in biophar